VENUS REMEDIES
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Venus Remedies along with daily highs, lows, percentage changes and volume trends, and, all financial information.
2.18₹ 17.05
As on Dec 16, 2025, 4:01 PM IST
Venus Remedies Price Performance
Today's LowToday's High
₹750.00₹808.90
₹799.00
52 Weeks' Low52 Weeks' High
₹272.20₹839.95
₹799.00
Open Price
₹778.00
Prev. Close
₹781.95
Volume
1,916
Over the last 5 years, the share price of Venus Remedies has gained 41.67% CAGR. Over the past year, the corresponding return has been 145.24%.
Venus Remedies’s current P/E of 15.19x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.
Venus Remedies Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Venus Remedies | 6.67 | 43.76 | 81.08 | 79.39 | 145.24 | 61.59 | 41.67 |
| Sun Pharmaceutical Industries | 0.37 | 1.08 | 10.67 | 5.77 | -1.52 | 21.53 | 25.34 |
| Divi's Laboratories | 0.78 | -2.79 | 4.05 | -5.20 | 8.35 | 24.02 | 11.26 |
| Torrent Pharmaceuticals | -0.32 | -1.72 | 6.16 | 14.42 | 11.63 | 32.88 | 21.89 |
| Cipla | 0.62 | -2.36 | -3.74 | -1.76 | 3.57 | 11.25 | 13.78 |
| Dr. Reddy's Laboratories | 2.63 | 2.77 | -2.41 | -5.03 | 0.72 | 14.06 | 4.88 |
| Lupin | 1.61 | 1.62 | 1.64 | 3.70 | 1.10 | 41.93 | 16.77 |
| Zydus Lifesciences | -0.65 | -2.18 | -11.70 | -6.17 | -7.50 | 30.86 | 14.27 |
| Mankind Pharma | -3.34 | -6.17 | -18.01 | -11.05 | -21.72 | 13.94 | 8.14 |
| Aurobindo Pharma | 1.20 | -4.96 | 7.68 | 2.79 | -5.56 | 38.60 | 6.07 |
| Alkem Laboratories | -0.05 | -1.07 | 2.81 | 16.33 | 4.06 | 22.89 | 14.34 |
| Abbott India | -1.06 | -6.01 | -10.15 | -12.11 | -1.54 | 10.48 | 11.34 |
| Glenmark Pharmaceuticals | 1.07 | 5.01 | -5.68 | 16.43 | 26.28 | 67.39 | 30.16 |
| Laurus Labs | -2.05 | -2.13 | 11.77 | 47.15 | 74.44 | 37.06 | 24.17 |
| Biocon | 0.17 | -8.81 | 6.69 | 7.53 | 8.64 | 13.04 | -3.54 |
| GlaxoSmithKline Pharmaceuticals | 1.27 | 4.07 | -5.33 | -22.99 | 13.76 | 24.52 | 10.81 |
| Anthem Biosciences | 2.36 | 1.27 | -18.88 | -7.73 | -7.73 | -2.65 | -1.60 |
| Ipca Laboratories | -1.71 | -2.53 | 8.90 | 4.69 | -8.88 | 18.58 | 4.86 |
| Ajanta Pharma | -0.99 | 3.60 | 1.60 | -0.11 | -10.51 | 29.76 | 18.13 |
| J B Chemicals & Pharmaceuticals | -0.40 | -1.78 | 6.36 | 3.17 | -1.82 | 19.09 | 26.95 |
Over the last one year, Venus Remedies has gained 145.24% compared to peers like Sun Pharmaceutical Industries (-1.52%), Divi's Laboratories (8.35%), Torrent Pharmaceuticals (11.63%). From a 5 year perspective, Venus Remedies has outperformed peers relative to Sun Pharmaceutical Industries (25.34%) and Divi's Laboratories (11.26%).
Venus Remedies Financials
Venus Remedies Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 789.59 | 791.74 |
| 10 | 770.36 | 771.02 |
| 20 | 717.76 | 720.83 |
| 50 | 565.62 | 619.57 |
| 100 | 521.38 | 547.32 |
| 200 | 443.59 | 479 |
Venus Remedies Share Holding Pattern
In the latest quarter, Venus Remedies remained same as its previous close in promoter holding, while DII stake increased to 0.75%, FII holding fell to 1.86%, and public shareholding moved down to 55.62% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Venus Remedies Corporate Actions
Date Time | Announcement |
|---|---|
| Dec 13, 2025, 6:13 AM IST | Venus Remedies L - Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shar |
| Dec 12, 2025, 11:12 PM IST | Venus Remedies L - Shares Re-Lodged For Transfer Cum Demat Pursuant To SEBI Circular No. SEBI/HO/MIRSD/MIRSD-Pod/P/CIR/2025/9 |
| Dec 08, 2025, 4:25 PM IST | Venus Remedies L - Venus Remedies Marks Completion Of AMR Licensing Milestones With Final ?11 Crore Payment |
| Dec 01, 2025, 3:58 PM IST | Venus Remedies L - Update On Resolution Of Income Tax Matters And Elimination Of Contingent Liability. |
| Nov 28, 2025, 10:37 PM IST | Venus Remedies L - Social Media Communication Regarding Special Window For Re-Lodgement Of Transfer Requests Of Physical Shar |
About Venus Remedies
Venus Remedies Ltd. is a Public Limited Listed company incorporated on 15/09/1989 and has its registered office in the State of Chandigarh, India. Company's Corporate Identification Number(CIN) is L24232CH1989PLC009705 and registration number is 009705. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 639.46 Cr. and Equity Capital is Rs. 13.37 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- AddressS.C.O. 857, C. No. 10, 2nd Floor, NAC Manimajra, Chandigarh Chandigarh 160101
- Contact
Management
- Mr. Pawan ChaudharyChairman & Managing Director
- Dr.(Mrs.) Manu ChaudharyJoint Managing Director
- Mr. Peeyush JainDeputy Managing Director
- Mr. Ashutosh JainExecutive Director
- Mr. Akshansh ChaudharyExecutive Director
- Dr.(Mrs.) Savita GuptaIndependent Director
- Mr. N P S MongaIndependent Director
- Mr. Navdeep SudIndependent Director
- Mr. Jagdish Chander SharmaIndependent Director
- Dr. Anil KumarIndependent Director
FAQs on Venus Remedies Share Price
What is the share price of Venus Remedies?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Venus Remedies is ₹799.00 as on Dec 16, 2025.
What kind of stock is Venus Remedies?
The Venus Remedies is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Venus Remedies?
The market cap of Venus Remedies is ₹1,068.02 Cr as on Dec 16, 2025.
What are today's High and Low prices of Venus Remedies?
Today’s highest and lowest price of Venus Remedies are ₹808.90 and ₹750.00.
What are the 52 Week High and 52 Week Low of Venus Remedies?
The 52-week high/low is the highest and lowest price at which Venus Remedies stock has traded in the past 52-week or nearly a year. The 52-week high of Venus Remedies is ₹839.95 and 52-week low of Venus Remedies is ₹272.20 as on Dec 16, 2025.
How has the Venus Remedies performed historically in terms of returns?
The Venus Remedies has shown returns of 2.18% over the past day, 43.76% for the past month, 81.08% over 3 months, 145.24% over 1 year, 61.59% across 3 years, and 41.67% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Venus Remedies?
P/E ratio of and PB ratio of Venus Remedies are 15.19 and 1.90 on Dec 16, 2025. While the company gives a dividend yield of 0.00 per annum.
✕
Market Pulse